Arkolith/Insider Trading/IONS/Form 4

Klein Joseph III

DirectorIONIS PHARMACEUTICALS INC (IONS) · full profile →Form 4 · filed Jul 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$910K
Net Open-Market Flow
-$910K
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)12K$39.94$460K23K
Jul 1, 2026Sell(S)99$79.45$8K22K
Jul 1, 2026Sell(S)11K$79.04$903K11K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)12K—$00
Jul 1, 2026Grant(A)5K—$05K
Jul 1, 2026Grant(A)2K—$016K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000874015-26-000229) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML